| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT06318533 A Clinical Study of CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related… |
date change Primary completion pushed: 2026-03-13 -> 2026-12-13 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1 | |||
| NCT07316907 | A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic… | Hematologic Malignancies | Not Yet Recruiting |
| NCT07316920 | A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell… | Relapsed/Refractory B-cell Lymphoma | Not Yet Recruiting |
| Early Phase 1 | |||
| NCT06976437 | A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell… | B Cell Lymphoma | Recruiting |
| NCT06318533 | A Clinical Study of CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related… | Autoimmune Diseases | Recruiting |